[go: up one dir, main page]

WO2005081171A3 - Calculateur de bol d'insuline pour dispositif de communications mobiles - Google Patents

Calculateur de bol d'insuline pour dispositif de communications mobiles Download PDF

Info

Publication number
WO2005081171A3
WO2005081171A3 PCT/ZA2005/000040 ZA2005000040W WO2005081171A3 WO 2005081171 A3 WO2005081171 A3 WO 2005081171A3 ZA 2005000040 W ZA2005000040 W ZA 2005000040W WO 2005081171 A3 WO2005081171 A3 WO 2005081171A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood glucose
communication device
insulin
mobile communication
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ZA2005/000040
Other languages
English (en)
Other versions
WO2005081171A2 (fr
Inventor
Edward Henry Mathews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2005081171A2 publication Critical patent/WO2005081171A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005081171A3 publication Critical patent/WO2005081171A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne un dispositif permettant une meilleure surveillance de la glycémie. Ce dispositif est constitué d'une application mise en oeuvre sur un dispositif de communications mobiles utilisant des algorithmes de prédiction de la glycémie et de calcul du bol d'insuline. L'invention capture par ses organes d'entrée l'heure et les détails d'événements tels que la prise d'aliments, l'exercice physique, la prise de médicaments (insuline), la glycémie, et d'autres paramètres spécifiques de l'utilisateurs tels que la sensibilité à l'insuline et aux glucides, le poids, le niveau d'activité, etc. L'invention utilise alors normalement les algorithmes pour calculer le type et l'importance de la mesure correctrice à prendre pour agir sur la glycémie. La suggestion s'affiche sur l'organe de sortie du dispositif. La configuration normale de l'invention est un téléphone mobile exécutant un applicatifs utilisant les ressources du dispositif de communications. Pour introduire l'information, on utilise le clavier, les résultats s'affichant à l'écran du dispositif de communications mobiles. L'utilisation régulière du dispositif permet une meilleure gestion du régime insulinique par l'utilisateur, ce qui permet une meilleure gestion de la glycémie, et réduit d'autant les complications diabétiques associées à l'hyperglycémie comme à l'hypoglycémie.
PCT/ZA2005/000040 2004-02-19 2005-02-18 Calculateur de bol d'insuline pour dispositif de communications mobiles Ceased WO2005081171A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA2004/1345 2004-02-19
ZA200401345 2004-02-19

Publications (2)

Publication Number Publication Date
WO2005081171A2 WO2005081171A2 (fr) 2005-09-01
WO2005081171A3 true WO2005081171A3 (fr) 2006-09-14

Family

ID=34887953

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2005/000040 Ceased WO2005081171A2 (fr) 2004-02-19 2005-02-18 Calculateur de bol d'insuline pour dispositif de communications mobiles

Country Status (1)

Country Link
WO (1) WO2005081171A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023256A1 (fr) * 2007-08-02 2009-02-11 Novo Nordisk A/S Surveillance de l'administration de médicaments
WO2010062010A1 (fr) * 2008-11-26 2010-06-03 동진메디칼 주식회사 Dispositif de mesure du taux de glycémie comprenant une fonction de contrôle du taux de glycémie, et procédé de commande de celui-ci
HK1205576A1 (en) * 2012-07-11 2015-12-18 Caren Frances THOMSON Method, system and apparatus for setting insulin dosages for diabetics
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
WO2016061308A1 (fr) 2014-10-17 2016-04-21 Kahlbaugh Bradley E Prise en charge du syndrome métabolique chez l'être humain
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
WO2017031440A1 (fr) 2015-08-20 2017-02-23 Aseko, Inc. Conseiller de thérapie pour la gestion du diabète

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030176183A1 (en) * 2001-04-02 2003-09-18 Therasense, Inc. Blood glucose tracking apparatus and methods
US20030195404A1 (en) * 2000-09-22 2003-10-16 Knobbe Edward J. Method and apparatus for real-time control of physiological parameters

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030195404A1 (en) * 2000-09-22 2003-10-16 Knobbe Edward J. Method and apparatus for real-time control of physiological parameters
US20030176183A1 (en) * 2001-04-02 2003-09-18 Therasense, Inc. Blood glucose tracking apparatus and methods

Also Published As

Publication number Publication date
WO2005081171A2 (fr) 2005-09-01

Similar Documents

Publication Publication Date Title
WO2005081171A3 (fr) Calculateur de bol d'insuline pour dispositif de communications mobiles
Sun et al. Improving glycemic control in adults and children with type 1 diabetes with the use of smartphone-based mobile applications: a systematic review
CA2942251C (fr) Systeme de surveillance et prediction de dose de medicament
RU2717887C1 (ru) Приемник для приема данных об аналите и способ его работы
JP7042791B2 (ja) インスリン感受性を判断するためのシステムおよび方法
WO2008067284A3 (fr) Procédé, système et produit de programme informatique de détection d'activité physique par des changements du rythme cardiaque, l'évaluation de changement rapide d'états métaboliques, et applications de boucle de commande fermée et ouverte dans des diabètes
US20060137695A1 (en) System and method for determining insulin bolus quantities
US20180368737A1 (en) Personalized fitness tracking
CN105303027A (zh) 身体状况提示装置和系统、及提示信息输出方法
US20170100635A1 (en) Exercise suggestion device, exercise suggestion method, and exercise suggestion program
US20210187197A1 (en) Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
KR20170050190A (ko) 활동 가이드 정보 제공 방법 및 이를 지원하는 전자 장치
US20170112445A1 (en) Heart Rate Detection with Multi-Use Capacitive Touch Sensors
Veluvali et al. Impact of digital health interventions on glycemic control and weight management
Healy et al. Monitoring glycemia in diabetes
Rodriguez-Rodriguez et al. Variables to Be Monitored via Biomedical Sensors for Complete Type 1 Diabetes Mellitus Management: An Extension of the “On‐Board” Concept
Mohan et al. Expert consensus recommendations on time in range for monitoring glucose levels in people with diabetes: An Indian perspective
Rohm et al. Vasopressors and inotropes as predictors of mortality in acute severe cardiogenic shock treated with the impella device
EP4070334A1 (fr) Détermination du fait que des ajustements de recommandations d'insulinothérapie sont pris en compte
Roze et al. Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
Fairchild Changes in management and outcomes for children and adolescents with type 1 diabetes over the last 50 years
Shalitin et al. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
KR20120079376A (ko) 스마트폰에서 당뇨관리 앱기반 서비스 제공 방법
US20220105282A1 (en) Injection site determination systems and methods for injection site tracking and recommending injection sites
Stoet et al. Characteristics of people with optimally-managed type 1 diabetes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase